Partner Randy D. Gordon, chair of the Firm’s antitrust and trade regulation practice, authored an article for Law360 regarding the antitrust issues associated with the Bayer-Monsanto deal.
“Bayer can make a credible case that it and Monsanto are not — for the most part — competitors in the two market dimensions that count in any antitrust analysis. First, with respect to product markets, Bayer has focused on herbicides in the agricultural space, whereas Monsanto has focused on seeds and genetic technology.”
Subscribers can access the full article here.
Related Insights
14 January 2025
Events
Crypto Under a New Political Environment
Patrick Daugherty (Partner, Chicago) will be joining the Securities Traders Association of Chicago (STAC) as a panelist at their 99th Annual Mid-Winter Meeting.
14 January 2025
Health Care Law Today
Massachusetts: New Year, New Law — Governor Signs “An Act enhancing the market review process” (House Bill No. 5159)
On January 8, 2025, Governor Maura Healey signed into law H.B. 5159, “an Act enhancing the market review process.”
13 January 2025
Labor & Employment Law Perspectives
Illinois Human Rights Act Now Protects Employees With “Family Responsibilities”
As of January 1, 2025, Illinois became the latest in a minority of states and municipalities to expand employment protections for employees who act as family caregivers.